Biologic and targeted synthetic disease‐modifying anti‐rheumatic drugs improve body composition in rheumatoid arthritis patients more than conventional synthetic disease‐modifying anti‐rheumatic drugs: Results from the PRESENT study - Tada, Masahiro; Matsumoto, Yoshinari; Koike, Tatsuya; Mamoto, Kenji; Nakamura, Tomoyuki; Anno, Shohei; Iida, Takahiro; Goto, Hitoshi; Hidaka, Noriaki (International Journal of Rheumatic Diseases, 2024)